Sun Pharma Signs a License Agreement with Rockwell Medical for Triferic in India
Shots: Rockwell to receive up front, milestones and royalties on sales of Triferic. Sun Pharma to get an exclusive right to develop &
[Read More...]
India
Eris Lifesciences Acquires Novartis’ Zomelis (vildagliptin) in India for $13M
Shots: Eris Lifesciences acquired Novartis’ novel therapy Zomelis for $13M (~INR 93 crore) and will initiate the commercialization of product from Dec 10,
[Read More...]
Octavus Consulting Collaborates with IBCI for Delivering of Professional Educational Programs in India from 2020
Shots: The IBCI educational programs will focus on providing perspectives on Business & Competitive Intelligence role in every industry for professionals from all
[Read More...]
Lupin Launches Smart Device for Metered-Dose Inhalers to Support Treatment of Respiratory Diseases in India
Shots: Lupin in collaboration with Aptar Pharma launch ADHERO, a smart device designed to help patients with chronic respiratory diseases by tracking MDI
[Read More...]
Johnson & Johnson Vision Launches TECNIS Eyhance Monofocal Intraocular Lens for Post Cataract Surgery Patients in India
Shots: J&J Vision launches TECNIS Eyhance monofocal IOL to provide the advance solution for patients who have undergone cataract removal surgery The launch
[Read More...]
Cipla to Acquire Venus Remedies’ Elores to Strengthen its Critical Care Footprints in India
Shots: Cipla acquires Venus’ anti-infective products, Elores to robust its presence in Indian critical care space as a part of its agenda to
[Read More...]
Zentiva to Acquire Sanofi’s Ankleshwar Manufacturing Facility in India
Shots: Sanofi signs a business transfer agreement with Zentiva to sell its manufacturing facility in Ankleshwar, India. In H1’19, Zentiva enhanced its network
[Read More...]
Dr. Reddy’s Laboratories Launches Versavo (biosimilar, bevacizumab) for Multiple Cancer Indications in India
Shots: Dr. Reddy’s has launched Versavo (bevacizumab), a biosimilar of Roche’s Avastin in 100mg and 400mg single use vials for the treatment of
[Read More...]
Glenmark’s Combination Therapy of Remogliflozin Etabonate + Metformin Hydrochloride Receive Approval for Type 2 Diabetes in India
Shots: Glenmark has received the regulatory approval to commercialize the combination therapy of remogliflozin etabonate (100mg) + metformin hydrochloride (500/1000mg) as an adjunct
[Read More...]
Torrent Signs a Non-Exclusive License Agreement with Glenmark to Co-Commercialize Remogliflozin Etabonate for Type 2 Diabetes in India
Shots: Glenmark to receive up front, license fee and royalties on sales and is responsible to manufacture and supply Remogliflozin. Torrent to get
[Read More...]